With Taxol, chromosomes divide and get conquered | Science News

Support Science Journalism

Science News is a nonprofit.

Support us by subscribing now.

News in Brief

With Taxol, chromosomes divide and get conquered

New mechanism discovered for decades-old cancer drug

4:29pm, March 26, 2014

MIXED UP  Human breast cancer cells from women treated with the chemotherapy drug paclitaxel abnormally split into more than two cells (shown in a micrograph, with alpha-tubulin, a protein involved in cell division, in red and DNA in blue). The progeny cells have jumbled chromosomes and tend to die.

View the video

A popular cancer drug has previously undiscovered tricks up its sleeve.

The best-selling chemotherapy drug paclitaxel (Taxol) treats breast, lung, ovarian and other cancers. Animal studies and experiments on human cells in lab dishes had suggested the drug worked by freezing cells in the act of dividing. But those studies used drug doses much higher than tumor cells in a patient’s body would encounter.

So Beth Weaver of the University of Wisconsin–Madison and colleagues measured drug levels in breast tumors taken from women who had been treated with paclitaxel before surgery. Instead of stopping cell division, low, clinically relevant doses of the drug caused cells to pull their chromosomes in multiple directions, the researchers found. Cells caught in the multidirectional tug-of-war died after the split because their chromosomes had been scrambled, Weaver

This article is only available to Science News subscribers. Already a subscriber? Log in now.
Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content